pnr 2022
DOI: 10.47750/pnr.2022.13.s01.56
|View full text |Cite
|
Sign up to set email alerts
|

The evaluation of Paclitaxel effects on the Caco-2 cell line of colon cancer patients

Abstract: Background: Colon cancer is considered a malignant neoplasm. Paclitaxel is anti-carcinogenic chemotherapy that stimulates the apoptosis of cancer cells.Objective: This study aims to know the effect of paclitaxel on the level of Reactive oxygen species (ROS) on Caco-2 of colon cancer cells by the High-content screening technique.Methods: Normal and cancerous human colon cells (Caco-2cell lines) were cultured, then treated with paclitaxel at two different quantitative doses (100 µg/ml) and (200 µg/ml) for 1-7 da… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Publication Types

Select...

Relationship

0
0

Authors

Journals

citations
Cited by 0 publications
references
References 21 publications
0
0
0
Order By: Relevance

No citations

Set email alert for when this publication receives citations?